Minamimoto T, Nagai Y, Oyama K
Proc Jpn Acad Ser B Phys Biol Sci. 2024; 100(8):476-489.
PMID: 39401901
PMC: 11535006.
DOI: 10.2183/pjab.100.030.
Li D, Yan X, Xing Y, Yan J, Wang J, Zhang H
Curr Neuropharmacol. 2024; 22(13):2240-2255.
PMID: 38333970
PMC: 11337692.
DOI: 10.2174/1570159X22999240131122455.
Nguyen Q, Klein P, Xie C, Benthall K, Iafrati J, Homidan J
Nat Commun. 2024; 15(1):601.
PMID: 38238329
PMC: 10796428.
DOI: 10.1038/s41467-024-44853-8.
Pereira M, Ayana R, Holt M, Arckens L
Front Cell Dev Biol. 2023; 11:1193130.
PMID: 37534103
PMC: 10393042.
DOI: 10.3389/fcell.2023.1193130.
Phillips J, Hutchings C, Djamgoz M
Bioelectricity. 2021; 3(1):14-26.
PMID: 34476375
PMC: 8390776.
DOI: 10.1089/bioe.2020.0051.
Absolute and Dose-Adjusted Serum Concentrations of Clozapine in Patients Switching vs. Maintaining Treatment: An Observational Study of 1979 Patients.
Kylleso L, Smith R, Karlstad O, Andreassen O, Molden E
CNS Drugs. 2021; 35(9):999-1008.
PMID: 34417726
PMC: 8408068.
DOI: 10.1007/s40263-021-00847-4.
Evidence in primates supporting the use of chemogenetics for the treatment of human refractory neuropsychiatric disorders.
Roseboom P, Mueller S, Oler J, Fox A, Riedel M, Elam V
Mol Ther. 2021; 29(12):3484-3497.
PMID: 33895327
PMC: 8636156.
DOI: 10.1016/j.ymthe.2021.04.021.
Chemogenetic approaches to identify metabolically important GPCR signaling pathways: Therapeutic implications.
Meister J, Wang L, Pydi S, Wess J
J Neurochem. 2021; 158(3):603-620.
PMID: 33540469
PMC: 9387560.
DOI: 10.1111/jnc.15314.
Chemogenetic manipulation of microglia inhibits neuroinflammation and neuropathic pain in mice.
Yi M, Liu Y, Liu K, Chen T, Bosco D, Zheng J
Brain Behav Immun. 2020; 92:78-89.
PMID: 33221486
PMC: 7897256.
DOI: 10.1016/j.bbi.2020.11.030.
Combining designer receptors exclusively activated by designer drugs and neuroimaging in experimental models: A powerful approach towards neurotheranostic applications.
Peeters L, Missault S, Keliris A, Keliris G
Br J Pharmacol. 2019; 177(5):992-1002.
PMID: 31658365
PMC: 7042113.
DOI: 10.1111/bph.14885.
Off-Target Effects of Clozapine-N-Oxide on the Chemosensory Reflex Are Masked by High Stress Levels.
Martinez V, Saldana-Morales F, Sun J, Zhu P, Costa-Mattioli M, Ray R
Front Physiol. 2019; 10:521.
PMID: 31178741
PMC: 6538678.
DOI: 10.3389/fphys.2019.00521.
Designer Drugs for Designer Receptors: Unlocking the Translational Potential of Chemogenetics.
Yizhar O, Wiegert J
Trends Pharmacol Sci. 2019; 40(6):362-364.
PMID: 31072638
PMC: 6548557.
DOI: 10.1016/j.tips.2019.04.010.
Pharmacokinetic and pharmacodynamic actions of clozapine-N-oxide, clozapine, and compound 21 in DREADD-based chemogenetics in mice.
Jendryka M, Palchaudhuri M, Ursu D, van der Veen B, Liss B, Katzel D
Sci Rep. 2019; 9(1):4522.
PMID: 30872749
PMC: 6418145.
DOI: 10.1038/s41598-019-41088-2.
Ultrapotent chemogenetics for research and potential clinical applications.
Magnus C, Lee P, Bonaventura J, Zemla R, Gomez J, Ramirez M
Science. 2019; 364(6436).
PMID: 30872534
PMC: 7252514.
DOI: 10.1126/science.aav5282.
DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based DREADDs and .
Thompson K, Khajehali E, Bradley S, Navarrete J, Huang X, Slocum S
ACS Pharmacol Transl Sci. 2019; 1(1):61-72.
PMID: 30868140
PMC: 6407913.
DOI: 10.1021/acsptsci.8b00012.
A Comparative Study of the Pharmacokinetics of Clozapine -Oxide and Clozapine -Oxide Hydrochloride Salt in Rhesus Macaques.
Allen D, Carlson T, Xiong Y, Jin J, Grant K, Cuzon Carlson V
J Pharmacol Exp Ther. 2018; 368(2):199-207.
PMID: 30523062
PMC: 6337003.
DOI: 10.1124/jpet.118.252031.
The use of chemogenetic approaches in alcohol use disorder research and treatment.
Cheng Y, Wang J
Alcohol. 2018; 74:39-45.
PMID: 30442535
PMC: 6295360.
DOI: 10.1016/j.alcohol.2018.05.012.
Endocannabinoid control of the insular-bed nucleus of the stria terminalis circuit regulates negative affective behavior associated with alcohol abstinence.
Centanni S, Morris B, Luchsinger J, Bedse G, Fetterly T, Patel S
Neuropsychopharmacology. 2018; 44(3):526-537.
PMID: 30390064
PMC: 6333805.
DOI: 10.1038/s41386-018-0257-8.
The Central Amygdala Corticotropin-releasing hormone (CRH) Neurons Modulation of Anxiety-like Behavior and Hippocampus-dependent Memory in Mice.
Paretkar T, Dimitrov E
Neuroscience. 2018; 390:187-197.
PMID: 30170157
PMC: 6168391.
DOI: 10.1016/j.neuroscience.2018.08.019.
Silencing the insular-striatal circuit decreases alcohol self-administration and increases sensitivity to alcohol.
Jaramillo A, Van Voorhies K, Randall P, Besheer J
Behav Brain Res. 2018; 348:74-81.
PMID: 29660441
PMC: 5993624.
DOI: 10.1016/j.bbr.2018.04.007.